Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders

Introduction Despite the availability of subcutaneous desmopressin (1‐deamino‐8‐d‐arginine vasopressin, SC‐DDAVP) as a haemostatic agent for children with mild bleeding disorders, few publications specifically address the safety or efficacy of this mode of administration. Aim Our aim was to assess w...

Ausführliche Beschreibung